The CCN6 gene helps cartilage and growing bones stay strong and well organized, especially in joints. If it does not work properly, children may gradually develop a rare inherited condition that causes joint stiffness, pain, enlarged finger joints, changes in the hips and spine, and short stature. Symptoms can look like juvenile arthritis, but the main problem is abnormal cartilage and bone development rather than inflammation.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or managing processes in the body. Some genes hold the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly help regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to look into this subject more closely, you can read more in the LearnHub.
Overview
CCN6Gene function
What if the gene works
The CCN6 gene helps cartilage cells stay healthy and supports normal joint and bone growth. Its protein helps maintain the tissue around these cells, which supports smooth movement and skeletal development.
Risk
What if the gene does not work
More disruptive variants in the CCN6 gene can cause progressive pseudorheumatoid dysplasia, a condition affecting bone and joint growth. People may develop childhood stiffness, enlarged joints, pain, and short stature, with timing and severity varying by variant.
Treatment
What does that mean for your treatment
No CCN6-specific treatment or drug choice is currently established for pathogenic variants in the CCN6 gene. The CCN6 gene is being studied as a biomarker and possible drug target in some cancers, but this research has not led to approved CCN6-directed treatment.
Conditions associated with CCN6
Gene function
What if the gene works
In joints and growing bones, the CCN6 gene helps tissues stay organized and resilient. It supports communication between cells and the supportive material around them, especially in cartilage. This helps with healthy joint surfaces and steady bone shaping over time.
The CCN6 gene helps cartilage cells maintain the supportive material around them. This material cushions joints and helps joint surfaces stay smooth during everyday movement.
Its protein works outside cells, where it helps nearby cells exchange growth and maintenance signals. That coordination supports a balanced pattern of cartilage cell activity.
In growing bones and joints, the CCN6 gene supports orderly tissue development. This role is part of how the body maintains healthy cartilage and bone growth over time.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and help create normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CCN6 gene can change how the CCN6 protein folds, is released from the cell, or connects with nearby matrix proteins that help cartilage stay organized. Understanding how CCN6 gene variants affect cartilage cells helps explain why milder variants may leave some protein activity, while more disruptive variants often lead to little or no working protein. In progressive pseudorheumatoid dysplasia, this difference can influence how early joint and bone changes appear and how marked they become.
How variants are linked to conditions
Pathogenic variants in both copies of the CCN6 gene cause progressive pseudorheumatoid dysplasia, also called progressive pseudorheumatoid arthropathy of childhood. People with this condition often have joint stiffness, swelling, pain, changes in the spine and hips, and short stature. Finding pathogenic variants in both copies of the CCN6 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widely present in the general population. Most do not have a direct effect on health and simply contribute to natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CCN6, risk is driven mainly by inheritance rather than lifestyle. A child is most likely to be affected when both parents carry a changed CCN6 copy, so family history and parents being biologically related can raise the chance. There is not enough evidence to say that diet, exercise, or other daily habits change this genetic risk.
Inheritance of CCN6 variants
Variants in the CCN6 gene are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy from each parent, and both parents are typically healthy carriers. When both parents carry a CCN6 gene variant, each pregnancy has a 25% chance of a child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither variant. In practical terms, the CCN6 inheritance pattern affects sons and daughters equally.
What does my CCN6 result mean for my family?
For families with a disease-causing change in the CCN6 gene, close relatives may also carry the same change. Brothers and sisters may also be affected, while parents are often healthy carriers who do not have symptoms. Children of someone with a CCN6-related condition will usually be carriers, and they may be affected only if the other parent also carries a disease-causing CCN6 change.
Genetic information
Genetic testing
How you find out about variants
CCN6 genetic testing usually uses a blood or saliva sample to read the CCN6 gene and look for variants. Labs may examine the DNA code for small changes and check for missing or extra pieces of the gene. Results may find a variant, find no variant, or show a change that needs more interpretation.
When should I consider getting a genetic test?
Consider testing the CCN6 gene if a child or young adult has unexplained joint stiffness, enlarged finger or knee joints, slow walking, or short stature, especially when arthritis tests are normal. Testing can help confirm an inherited condition affecting bone and cartilage growth and may also help families when the condition is already known in relatives.
A genetic result is only one part of your health story
A genetic finding can provide useful information, but how much it explains depends on the condition and on the kind of variant present. Lifestyle, environment, age, and medical history, among other factors, influence how the body functions over time. For some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is most helpful when considered with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication may work well for one person, have less effect in another, or cause more side effects in someone else. Differences in how the body absorbs, breaks down, transports, or responds to a drug are common and can influence both treatment benefit and sensitivity.
What is Pharmacogenetics?
Pharmacogenetics examines the way genetic differences affect how people respond to medicines. It studies gene-drug relationships to help explain why the same treatment can work differently from one person to another. With many medications, genes can influence both how the body handles a drug and how strong its effects are. This information can support more personalized and better informed treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the CCN6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about side effects, new symptoms, or changes in treatment are best discussed with your doctor.
History
CCN6 was first identified in the late 1990s as WISP3, one of several genes described during research on growth-related cell signals. Soon after, researchers linked variants in the CCN6 gene to progressive pseudorheumatoid dysplasia, a rare inherited condition that affects joints and bone growth. This helped distinguish the condition from inflammatory arthritis and gave families a clearer genetic explanation. From these first observations, research expanded steadily. Scientific classifications changed as researchers learned more about the gene, and WISP3 was later renamed the CCN6 gene to reflect its place in the broader CCN gene family.